Cargando…

Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment

Glioblastoma (GBM) is the most common malignant primary brain tumor with a poor prognosis. The current standard treatment regimen represented by temozolomide/radiotherapy has an average survival time of 14.6 months, while the 5-year survival rate is still less than 5%. New therapeutics are still hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Lin, Feng, Yicheng, Gao, Sai, Mu, Qingchun, Liu, Chaoyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655904/ https://www.ncbi.nlm.nih.gov/pubmed/34899350 http://dx.doi.org/10.3389/fphar.2021.786700

Ejemplares similares

Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancer
por: Saha, Tanmoy, et al.
Publicado: (2021)

Lipid-engineered nanotherapeutics for cancer management
por: Fernandez-Fernandez, Alicia, et al.
Publicado: (2023)

Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
por: Lee, David, et al.
Publicado: (2021)

Neurogenic Hypertension, the Blood–Brain Barrier, and the Potential Role of Targeted Nanotherapeutics
por: Lamptey, Richard Nii Lante, et al.
Publicado: (2023)

Editorial: New Approaches in Toxicity Testing of Nanotherapeutics
por: Kalangi, Suresh K., et al.
Publicado: (2022)

Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma
por: Grégoire, Hélène, et al.
Publicado: (2020)

Exosomes: Promising Delivery Tools for Overcoming Blood-Brain Barrier and Glioblastoma Therapy
por: Khatami, Seyyed Hossein, et al.
Publicado: (2023)

Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier
por: Sharma, Rohit K., et al.
Publicado: (2021)

Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease
por: Seshadri, Dhruv R., et al.
Publicado: (2018)

ITGA2 as a potential nanotherapeutic target for glioblastoma
por: Guo, Peng, et al.
Publicado: (2019)

Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme
por: Lim, Xin Yuan, et al.
Publicado: (2023)

DDEL-15. NANOTHERAPEUTIC TARGETING OF TUMOR ENDOTHELIUM FOR ENHANCING DRUG DELIVERY PAST THE BLOOD-BRAIN BARRIER
por: Kiguchi, Hiro, et al.
Publicado: (2020)

New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro
por: Salaroglio, Iris Chiara, et al.
Publicado: (2018)

Drug Transport and Metabolism in the Blood–Brain Barrier
por: Kapitulnik, Jaime
Publicado: (2011)

Perlecan and the Blood-Brain Barrier: Beneficial Proteolysis?
por: Roberts, Jill, et al.
Publicado: (2012)

The blood-brain barrier and methamphetamine: open sesame?
por: Turowski, Patric, et al.
Publicado: (2015)

Nanotechnology Based Approaches in Phage Therapy: Overcoming the Pharmacological Barriers
por: Kaur, Sandeep, et al.
Publicado: (2021)

Iron (II) Polypyridyl Complexes as Antiglioblastoma Agents to Overcome the Blood-Brain Barrier and Inhibit Cell Proliferation by Regulating p53 and 4E-BP1 Pathways
por: Zhu, Huili, et al.
Publicado: (2019)

Overcoming delivery barriers in immunotherapy for glioblastoma
por: Rui, Yuan, et al.
Publicado: (2021)

Barriers to overcoming immunotherapy resistance in glioblastoma
por: Gillette, Julia S., et al.
Publicado: (2023)

Theranostic Strategy of Focused Ultrasound Induced Blood-Brain Barrier Opening for CNS Disease Treatment
por: Chen, Ko-Ting, et al.
Publicado: (2019)

Ultrasound Combined With Microbubbles Loading BDNF Retrovirus to Open Blood–Brain Barrier for Treatment of Alzheimer’s Disease
por: Wang, Feng, et al.
Publicado: (2021)

Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures
por: Zhang, Issan, et al.
Publicado: (2020)

Purinergic signaling: A gatekeeper of blood-brain barrier permeation
por: Wang, Yuemei, et al.
Publicado: (2023)

Methamphetamine effects on blood-brain barrier structure and function
por: Northrop, Nicole A., et al.
Publicado: (2015)

A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment
por: Wang, Da, et al.
Publicado: (2019)

Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials
por: Bukhari, Syed Nasir Abbas
Publicado: (2022)

Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers
por: Durymanov, Mikhail, et al.
Publicado: (2018)

Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
por: Raut, Sangram, et al.
Publicado: (2018)

Gene Therapy for Cystic Fibrosis Lung Disease: Overcoming the Barriers to Translation to the Clinic
por: Donnelley, Martin, et al.
Publicado: (2018)

Overcoming barriers: a review on innovations in drug delivery to the middle and inner ear
por: Delaney, Derek S., et al.
Publicado: (2023)

The Effects of Psychostimulant Drugs on Blood Brain Barrier Function and Neuroinflammation
por: Kousik, Sharanya M., et al.
Publicado: (2012)

Development of QSAR models to predict blood-brain barrier permeability
por: Faramarzi, Sadegh, et al.
Publicado: (2022)

Endoplasmic Reticulum Stress Mediates Methamphetamine-Induced Blood–Brain Barrier Damage
por: Qie, Xiaojuan, et al.
Publicado: (2017)

Experimental Study of Almonertinib Crossing the Blood-Brain Barrier in EGFR-Mutant NSCLC Brain Metastasis and Spinal Cord Metastasis Models
por: Zhang, Yuhan, et al.
Publicado: (2021)

The Protective Effect of Liquiritin in Hypoxia/Reoxygenation-Induced Disruption on Blood Brain Barrier
por: Li, Mengting, et al.
Publicado: (2021)

Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies
por: Moorkens, Evelien, et al.
Publicado: (2016)

Storax Inhibits Caveolae-Mediated Transcytosis at Blood-Brain Barrier After Ischemic Stroke in Rats
por: Zhou, Min, et al.
Publicado: (2022)

Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers
por: Caprifico, Anna E., et al.
Publicado: (2020)

Hepatic Ischemia-Reperfusion Impairs Blood-Brain Barrier Partly Due to Release of Arginase From Injured Liver
por: Zhu, Liang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b7r6sa14becnq6e8a1hiq0g6m7